Largest Meta-Analysis Confirms Medical Marijuana Benefits for Cancer Symptoms Amid 133% Brain Damage Risk from Cannabis Hospital Visits

Recent scientific studies have revealed contrasting findings regarding cannabis use and its health impacts. A large meta-analysis identified as the largest ever conducted on medical marijuana for treating cancer symptoms found an overwhelming scientific consensus on its therapeutic benefits, suggesting a substantial basis for reconsidering cannabis's classification as a Schedule I substance. Conversely, other research indicates potential risks associated with cannabis use; specifically, middle-aged adults who sought hospital or emergency care due to cannabis use were found to be nearly twice as likely to develop dementia within five years. Additionally, studies on alcohol consumption have shown that even moderate weekly intake is linked to a 133% increased risk of brain damage. These findings contribute to ongoing discussions about the neurological and social effects of substances such as cannabis and alcohol.